Frankfurt - Delayed Quote EUR
Glycorex Transplantation AB (publ) (O33.F)
0.1835
-0.0055
(-2.91%)
At close: May 23 at 9:40:45 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
50,304
65,844
96,077
101,799
Total Liabilities Net Minority Interest
17,190
21,805
21,714
18,846
Total Equity Gross Minority Interest
33,114
44,039
74,363
82,953
Total Capitalization
33,114
44,349
75,050
84,016
Common Stock Equity
33,114
44,039
74,363
82,953
Capital Lease Obligations
6,703
10,561
8,732
7,367
Net Tangible Assets
13,960
21,467
36,471
42,656
Working Capital
4,311
11,607
29,618
37,036
Invested Capital
33,393
44,971
75,672
84,638
Tangible Book Value
13,960
21,467
36,471
42,656
Total Debt
6,982
11,493
10,041
9,052
Share Issued
73,853.9830
73,853.9830
73,853.9830
73,853.9830
Ordinary Shares Number
73,853.9830
73,853.9830
73,853.9830
73,853.9830
12/31/2021 - 8/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PFND Pathfinder Cell Therapy, Inc.
0.0001
0.00%
TNGNQ Tengion, Inc.
0.0000
0.00%
PZRXQ PhaseRx, Inc.
0.0002
0.00%
XENO Xeno Transplants Corporation
0.0001
0.00%
PROT Proteonomix, Inc.
0.0000
0.00%
DYN Dyne Therapeutics, Inc.
11.69
-1.76%
GMAB Genmab A/S
20.81
-1.05%
INCY Incyte Corporation
64.25
-0.41%
SEPN Septerna, Inc.
9.19
-3.06%
HUMA Humacyte, Inc.
2.5300
+5.42%